Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Theratechnologies Inc (NQ: THTX )

0.8210 +0.0109 (+1.35%)
Streaming Delayed Price Updated: 2:12 PM EDT, Mar 20, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 14,361
Open 0.8101
Bid (Size) 0.8200 (29)
Ask (Size) 0.8500 (7)
Prev. Close 0.8101
Today's Range 0.8101 - 0.8800
52wk Range 0.6984 - 2.765
Shares Outstanding 77,013,411
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Theratechnologies to Present Preclinical Data at AACR Demonstrating Synergy Between TH1902 and Anti-PD-L1 Immunotherapy in Cold Tumor Model
From Theratechnologies
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Tuesday
  Tuesday's morning session saw 84 companies set new 52-week lows. 
Via Benzinga

Performance

YTD
-16.22%
-16.22%
1 Month
-16.22%
-16.22%
3 Month
-9.75%
-9.75%
6 Month
-58.54%
-58.54%
1 Year
-68.18%
-68.18%

More News

Read More
Theratechnologies Is An Underappreciated HIV-Focused Company, Analyst Says
Via Benzinga
Theratechnologies Receives Nasdaq Notification Letter Regarding Share Price
From Theratechnologies
Via Globe NewsWire
Theratechnologies Inc. (NASDAQ:THTX) Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties
Via SBWire
Theratechnologies Reports Financial Results and Business Updates for the Fourth Quarter and Full Year Fiscal 2022
From Theratechnologies
Via Globe NewsWire
Theratechnologies Announces Amendment to its Term Loan Facility With Affiliates of Marathon Asset Management
From Theratechnologies
Via Globe NewsWire
Theratechnologies: Q3 Earnings Insights
Via Benzinga
Earnings Scheduled For February 28, 2023
Via Benzinga
Theratechnologies Presents New Tesamorelin Data Demonstrating Improvement of Metabolic Syndrome in People with HIV
From Theratechnologies
Via Globe NewsWire
Theratechnologies Announces Path to Resume TH1902 Clinical Development
From Theratechnologies
Via Globe NewsWire
Theratechnologies to Announce Fourth Quarter and Full Year 2022 Financial Results and Provide Business Update
From Theratechnologies
Via Globe NewsWire
Theratechnologies Inc. (NASDAQ:THTX) Investor Alert: Investigation over Possible Violations of Securities Laws
Via SBWire
Open Letter to Shareholders from CEO Paul Levesque
From Theratechnologies
Via Globe NewsWire
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Dow Drops 100 Points; Asana Shares Plummet
Via Benzinga
Why Cracker Barrel Shares Are Trading Lower By Around 13%? Here Are 42 Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Gold Down 1%; Samsara Shares Spike Higher
Via Benzinga
Dow Tumbles 300 Points After US Economy Adds 263,000 Jobs
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Theratechnologies Announces Update from Ongoing TH1902 Study
From Theratechnologies
Via Globe NewsWire
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Theratechnologies Reports Data Showing High Expression of Sortilin (SORT1) in Multiple Solid Tumors from Tissue Microarrays
From Theratechnologies
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
Via Benzinga
Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Business Update
From Theratechnologies
Via Globe NewsWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.